Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)

CompletedOBSERVATIONAL

Enrollment

2,100

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

March 3, 2023

Study Completion Date

March 3, 2023

Conditions

COVID-19 Vaccine Adverse Reaction

Interventions

BIOLOGICAL

mRNA COVID-19 vaccine

Children will be vaccinated according to standard local procedure

Trial Locations (1)

Fundacion para Investigación Biomedica Hospital Clinico San Carlos, Madrid

All Listed Sponsors

lead

Ana Belen Rivas Paterna

OTHER